Eli Lilly and Foghorn Therapeutics have joined forces for clinical trials on FHD-909, an oral cancer treatment. The collaboration aims to evaluate the effectiveness of FHD-909 on non-small-cell lung cancer patients.
Under Armour reports better-than-expected profit for Q3 and adjusts guidance for 2024. CEO optimistic about company's performance.
Snap's stock is plummeting after the company issued weak guidance, disappointing investors. Although there is still optimism about a potential recovery, Wall Street analysts have lowered their estimates and target prices on Snap shares. Mea...
Shares of Roblox surged 12% after exceeding expectations for quarterly bookings, reporting a 30% increase in revenue and $1.13 billion in bookings. Roblox expects continued growth in 2024.
Emerson Electric exceeds expectations in Q1 with significant sales boost and adjusted earnings, revises guidance for fiscal year, showcasing success of Intelligent Devices unit and Software and Control segment.
Ford Motor Co. reports strong quarterly revenue that surpasses expectations, showcasing its ability to excel in a challenging market. With a focus on its hybrid-vehicle business, Ford is well-positioned for future growth and success.
Kering will announce its financial results for 2023, including sales forecast, operating profit, and net profit. Gucci's turnaround process and challenges at Saint Laurent, Bottega Veneta, and Balenciaga impact Kering's earnings outlook.
Shares of Alibaba and other Chinese companies experience significant surge amidst speculations of government support. Caution advised as surge may be temporary market correction.